Literature DB >> 32810022

Transmastoid Labyrinthectomy for Menière's Disease: Experience and Outcomes.

Regan W Bergmark1,2,3, Robert S Semco3,4, Dunia Abdul-Aziz1,5, Steven D Rauch1,5.   

Abstract

OBJECTIVE: To characterize presurgical symptoms and treatment history and postoperative course in patients with medically recalcitrant Menière's disease undergoing transmastoid labyrinthectomy in the post-intratympanic gentamicin era. STUDY
DESIGN: Retrospective case series.
SETTING: Tertiary academic medical center. PATIENTS: All patients who underwent transmastoid labyrinthectomy for medically recalcitrant Menière's disease in 2003 to 2019 by the senior author.
INTERVENTIONS: Review of patients' medical records for: preoperative history of drop attacks, gentamicin injections, endolymphatic sac decompression or vestibular neurectomy, preoperative audiograms, length of hospital stay, postoperative complications, and persistent symptoms or challenging recovery. MAIN OUTCOME MEASURES: Presurgical clinical history and proximal postoperative outcomes.
RESULTS: Seventy-two patients with a mean age of 56.7 (standard deviation [SD] 10.7) were included. All cases were unilateral. Forty-three patients (59.7%) suffered from drop attacks. Sixty-two (86.1%) had failed sufficient symptom control with gentamicin injections. The mean preoperative word recognition score was 36.4% (SD 23.7) versus 95.1% (SD 8.5) in the contralateral ear. The mean pure-tone average (PTA) of the ipsilateral ear before surgery was 65.5 dB (SD 18.0) versus 16.2 (SD 13.5) for the contralateral ear. Mean hospital stay was 2.0 days (SD 0.87 days, range of 1-5 d). Three patients (4.2%) had prolonged postoperative vertigo.
CONCLUSIONS: Transmastoid labyrinthectomy at our center is performed for unilateral Menière's disease, generally when intratympanic gentamicin has failed. A majority of surgical patients suffer from drop attacks preoperatively. Hospital stay is typically brief.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32810022     DOI: 10.1097/MAO.0000000000002805

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  1 in total

1.  Efficacy and Durability of Intratympanic Gentamicin Treatment for Meniere's Disease.

Authors:  Yafeng Guan; Divya A Chari; Yu-Hsi Liu; Steven D Rauch
Journal:  Front Neurol       Date:  2021-12-09       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.